怎么翻译都不满意，求高手帮忙
这个帖子发布于 15 年零 103 天前，其中的信息可能已发生改变或有所发展。
About half of all Takayasu arteritis patients have chronic active disease for which GC therapy alone does not provide sustained remissions that allow withdrawal of treatment. Weekly low-dose MTX is an effective means of inducing remission and minimizing GC therapy and toxicity in most of these patients. Further long-term studies will be required to assess the durability of remission and the need for maintenance MTX therapy in this subset of Takayasu arteritis patients.
7 收藏点赞
